Alembic Pharmaceuticals Ltd
NSE:APLLTD

Watchlist Manager
Alembic Pharmaceuticals Ltd Logo
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Watchlist
Price: 1 028 INR 0.83% Market Closed
Market Cap: 202.1B INR
Have any thoughts about
Alembic Pharmaceuticals Ltd?
Write Note

Alembic Pharmaceuticals Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alembic Pharmaceuticals Ltd
Revenue Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Revenue
â‚ą63B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
13%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
â‚ą289.5B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Revenue
â‚ą265.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
â‚ą503.1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
â‚ą112.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
9%
M
Mankind Pharma Ltd
NSE:MANKIND
Revenue
â‚ą103.3B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Alembic Pharmaceuticals Ltd's Revenue?
Revenue
63B INR

Based on the financial report for Jun 30, 2024, Alembic Pharmaceuticals Ltd's Revenue amounts to 63B INR.

What is Alembic Pharmaceuticals Ltd's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Alembic Pharmaceuticals Ltd have been 5% over the past three years , 9% over the past five years , and 13% over the past ten years .

Back to Top